Robert W. Ross
Impact in
- Oncology top 0.2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Prostate Cancer Treatment and Research 27
- Prostate Cancer Diagnosis and Treatment 12
- Renal cell carcinoma treatment 4
-
- Hedgehog Signaling Pathway Studies 4
- Co-authors
- Louis Fehrenbacher (1 shared paper)Herbert I. Hurwitz (1 shared paper)Beth Rogers (1 shared paper)Thomas H. Cartwright (1 shared paper)John D. Hainsworth (1 shared paper)W. Heim (1 shared paper)Gwen Fyfe (1 shared paper)Jordan Berlin (1 shared paper)
- Journals
- Journal of Clinical Oncology (24 papers)Cancer (4 papers)Clinical Cancer Research (3 papers)British Journal of Urology (3 papers)Clinical Genitourinary Cancer (2 papers)
- Partner nations
- United StatesGreeceCanada
In The Last Decade
Robert W. Ross
59 papers receiving 10.8k citations
Robert W. Ross's Hit Papers
Peers
Comparison fields: 5 of 137
- Oncology 6.1k
- Hepatology 1.7k
- Cancer Research 1.9k
- Pulmonary and Respiratory Medicine 3.5k
- Molecular Biology 3.9k
Countries citing papers authored by Robert W. Ross
This map shows the geographic impact of Robert W. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Ross more than expected).
Fields of papers citing papers by Robert W. Ross
This network shows the impact of papers produced by Robert W. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Ross. The network helps show where Robert W. Ross may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert W. Ross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer Hit paper breakdown → | 2004 | 8433 |
| 2 | 2010 | 263 | |
| 3 | 2014 | 184 | |
| 4 | 2013 | 143 | |
| 5 | 2011 | 142 | |
| 6 | 2011 | 139 | |
| 7 | 2002 | 122 | |
| 8 | 2002 | 117 | |
| 9 | 2009 | 103 | |
| 10 | 2008 | 99 | |
| 11 | 2010 | 93 | |
| 12 | 2008 | 90 | |
| 13 | 2008 | 88 | |
| 14 | 2007 | 85 | |
| 15 | 2012 | 83 | |
| 16 | 2005 | 81 | |
| 17 | 2007 | 76 | |
| 18 | 2014 | 76 | |
| 19 | 2009 | 74 | |
| 20 | 2011 | 59 |
About Robert W. Ross
Robert W. Ross is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Surgery and Cancer Research, having authored 61 papers that have together received 11.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (27 papers), Prostate Cancer Diagnosis and Treatment (12 papers), Bladder and Urothelial Cancer Treatments (9 papers), Cancer Treatment and Pharmacology (5 papers), Urinary and Genital Oncology Studies (4 papers), Renal cell carcinoma treatment (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Hedgehog Signaling Pathway Studies (4 papers). The work is most often cited by research in Oncology (6.1k citations), Hepatology (1.7k citations), Cancer Research (1.9k citations), Pulmonary and Respiratory Medicine (3.5k citations) and Molecular Biology (3.9k citations). Robert W. Ross has collaborated with scholars based in United States, Greece and Canada. Frequent co-authors include Louis Fehrenbacher, Herbert I. Hurwitz, Beth Rogers, Thomas H. Cartwright, John D. Hainsworth, W. Heim, Gwen Fyfe, Jordan Berlin, William Novotny and Fairooz F. Kabbinavar. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Clinical Cancer Research, British Journal of Urology and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.